chartexchange

EWTX
Edgewise Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseOct 2, 2026 3:59:56 PM EDT
41.41USD+2.297%(+0.93)1,459,615
Pre-marketOct 2, 2026 8:07:30 AM EDT
40.71USD+0.568%(+0.23)
After-hoursOct 2, 2026 4:26:30 PM EDT
41.40USD-0.024%(-0.01)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Boulder, CO, USA
Previous Close
$40.48
Beta
1.30
52-Week High
$48.51 2026-09-17
52-Week Low
$14.25 2025-10-14
SMA 50
$42.88
SMA 200
$34.80
Avg. Vol 10D
1.91M
Avg. Vol 30D
1.48M
Avg. Vol 90D
1.47M
Relative Vol
0.99
108.60M
79.59M
0.4100%
2,600,000
226
Nov 5, 2026 (31d)
EWTX Profile

edgewise therapeutics is a biotechnology company focused on developing novel therapies for diseases involving skeletal muscle. the company is headquartered in boulder, co and received its series a financing from orbimed.

EWTX Performance
PeriodPriceDateChangeBeta
1W39.792026-09-28+3.97%1.076
1M43.072026-09-04-3.94%0.937
3M40.102026-07-06+3.17%1.468
6M32.832026-04-06+26.02%1.353
1Y15.652025-10-03+164.35%1.297
2Y28.402024-10-04+45.67%—
5Y17.612021-10-04+134.93%1.385
EWTX Stock Summary

Edgewise Therapeutics, Inc. Common Stock (NASDAQ:EWTX) stock price today is $41.37, and today's volume is 1,459,615. EWTX is up 2.200% today. The 30 day average volume is 1.48M. EWTX market cap is $4.49B with 108.60M shares outstanding.